when do you see weight loss with semaglutide Your First 3 Months on Semaglutide: How Much Can Lose Ozempic®? 7 Reasons You're Not Losing

For patients requiring even greater weight reductions, tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist now available in India, has demonstrated up to 20.9% body weight reduction in the SURMOUNT-1 trial, surpassing both semaglutide and dulaglutide

The most relevant safety considerations for patients with autoimmune diseases relate to semaglutide's known adverse effect profile rather than direct immune effects

Regulatory compliance and business overhead

J., Peng, L., Yang, Q., Chow, R

Buyer Takeaway: You won't know if you're approved until a licensed provider reviews your intake

Important safety considerations include risks of pancreatitis, hypoglycemia (when used with insulin or insulin secretagogues), acute kidney injury from dehydration, and gallbladder disease